NYU Langone Health to Enroll Healthy Volunteers in Clinical Trial for COVID-19 Vaccine
November 12, 2020
November 12, 2020
NEW YORK, Nov. 12 (TNSJou) -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release:
NYU Grossman School of Medicine is among the centers enrolling participants in a randomized phase 3 clinical trial to determine the safety and efficacy of the 2019 coronavirus disease (COVID-19) vaccine candidate developed by the pharmaceutical company AstraZeneca. The trial will seek to enroll up to 30,000 healthy study participants ag . . .
NYU Grossman School of Medicine is among the centers enrolling participants in a randomized phase 3 clinical trial to determine the safety and efficacy of the 2019 coronavirus disease (COVID-19) vaccine candidate developed by the pharmaceutical company AstraZeneca. The trial will seek to enroll up to 30,000 healthy study participants ag . . .